Dr. Butler-Ransohoff studied Chemistry at Heidelberg University and the MPI for Medical Research. After two years at Rockefeller University, he joined Bayer as Medicinal Chemist (1988). Since then he has had changing responsibilities such as Project Manager bringing new compounds to clinical proof-of-concept, several corporate staff functions such as Head R&D Coordination and leading a Therapeutic Cancer Vaccine Program. He has represented Bayer at HTGF since 2014 as part of his current role at Global External Innovation and Alliances. He is a visiting Professor at the Department for Infection and Immunity, Saint George’s University of London.